D. Tong

发表

The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression

D. Tong, 2021, Cancer Cell International.

Unravelling the Molecular Mechanisms of Prostate Cancer Evolution from Genotype to Phenotype.

D. Tong, 2021, Critical reviews in oncology/hematology.

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells

Junjiang Fu, Jing Xu, Jun Jiang, 2017, Oncotarget.

Clinical File Management, Translational Research and Continuing Education for Cancer: a Single-unit Experience

D. Tong, 2020 .

A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease

X. Yi, Y. Guan, Luofu Wang, 2018, Cancer biology & therapy.

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy

X. Yi, Y. Guan, Jun Jiang, 2018, Cancer biology & therapy.

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy

X. Yi, Y. Guan, Jing Xu, 2018, Cancer biology & therapy.

Immunotherapy in patients with metastatic castration-resistant prostate cancer: a meta-analysis of data from 7 phase III studies and 3 phase II studies

A. Zhang, D. Tong, Anqiang Zhang, 2022, Experimental Hematology & Oncology.

Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families

Jun Jiang, W. Lan, D. Tong, 2017, Medicine.

Novel genotype–phenotype correlations in five Chinese families with Von Hippel–Lindau disease

X. Yi, Y. Guan, Luofu Wang, 2018, Endocrine connections.

6-5-2018 Novel Genotype-Phenotype Correlations in Five Chinese Families with Von Hippel-Lindau Disease

X. Yi, Y. Guan, Luofu Wang, 2018 .

Giant bilateral adrenal myelolipomas in two Chinese families with congenital adrenal hyperplasia

Luofu Wang, Jun Jiang, V. Zhang, 2018, Endocrine connections.

9-1-2018 Giant Bilateral Adrenal Myelolipomas in Two Chinese Families with Congenital Adrenal Hyperplasia

Luofu Wang, Jun Jiang, Wei Zhang, 2018 .

A case report and literature review

X. Yi, Y. Guan, Yaoming Li, 2018 .

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2

J. Qin, Luofu Wang, Jun Jiang, 2020, The Journal of pathology.

5-19-2017 Resveratrol Enhances Polyubiquitination-Mediated ARV-7 Degradation in Prostate Cancer Cells

Junjiang Fu, Jun Jiang, Jing Xu, 2017 .

Carney Complex with PRKAR 1 A Gene Mutation : A Case Report and Literature Review

X. Yi, Y. Guan, Yaoming Li, 2018 .

Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective

D. Tong, Jun Jiang, Yao Zhang, 2021, Cancer Cell International.

Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

D. Tong, 2022, Journal for ImmunoTherapy of Cancer.

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT

Luofu Wang, Jun Jiang, Jingjing Xu, 2020, Frontiers in Oncology.

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT

Jing Xu, Yaoming Li, Jun Jiang, 2017, Cell Death and Disease.

Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.

Jing Xu, Jun Jiang, W. Lan, 2017, Cancer letters.

The roles of the COX2/PGE2/EP axis in therapeutic resistance

Luofu Wang, Jun Jiang, Jian Pang, 2018, Cancer and Metastasis Reviews.

HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma

X. Yi, Y. Guan, Yaoming Li, 2017, Cancer biology & therapy.

Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis

Jun Jiang, Peng Wang, N. Dai, 2020, Frontiers in Oncology.

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Luofu Wang, Yong He, Jun Jiang, 2018, Clinical Cancer Research.

A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review

Qingxing Feng, Jun Jiang, Jin Ye, 2017, Endocrine Pathology.

Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells

Qian Yi, D. Tong, Ke Li, 2022, Journal of oncology.

A Renal Cell Carcinoma with Biallelic Somatic TSC2 Mutation: Clinical Study and Literature Review.

Xiaochu Yan, Jun Jiang, Jin-hong Pan, 2019, Urology.

Publications from China in The Lancet, NEJM, and JAMA

Luofu Wang, Jun Jiang, D. Tong, 2013, The Lancet.

Metformin represses androgen‐dependent and androgen‐independent prostate cancers by targeting androgen receptor

Jun Jiang, D. Tong, Dianzheng Zhang, 2015, The Prostate.

The HIF/PHF8/AR axis promotes prostate cancer progression

Y. Wang, W. Yuan, S. Dong, 2016, Oncogenesis.

Complex behaviours—new targets against cancer

Jun Jiang, D. Tong, 2013, Nature Reviews Clinical Oncology.

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Jun Jiang, Jun-jie Yang, W. Lan, 2016, Oncotarget.

Novel technical modifications of hand-assisted laparoscopic dissection of a large obturator mass: A case report and literature review.

Jun Jiang, D. Tong, Jun Zhang, 2020, Oncology letters.

The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression

D. Tong, 2021, Cancer Cell International.

Targeting the JMJD6/TGF-β Axis in Prostate Cancer by Immunotherapy: A Potential Treatment Based on RNA Splicing

D. Tong, Y. Ni, Jing Xu, 2023, Medical Hypotheses.

The roles of the COX2/PGE2/EP axis in therapeutic resistance

Luofu Wang, Jun Jiang, Jian Pang, 2018, Cancer and Metastasis Reviews.

The emerging roles of histone demethylases in cancers.

D. Tong, Ying Tang, Peng Zhong, 2024, Cancer metastasis reviews.